| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.53 | 0.06 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |